CFDA-话题@MedSci

#CFDA#

184篇内容 | 1555人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1890701, encodeId=d15d1890e015b, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=多家中药生产厂商因“短斤缺两”被CFDA官网曝光, objectType=article, longId=127371, objectId=0c8a12e371b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c8a12e371b0, replyNumber=0, likeNumber=27, createdTime=2018-08-06, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c8a12e371b0, moduleTitle=多家中药生产厂商因“短斤缺两”被CFDA官网曝光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c8a12e371b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890645, encodeId=bcd41890645ad, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA正式发布管理办法！落实医疗器械临床试验机构由“资质认定”改为“备案管理”, objectType=article, longId=107850, objectId=518810e85086, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=518810e85086, replyNumber=0, likeNumber=30, createdTime=2018-01-29, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=518810e85086, moduleTitle=CFDA正式发布管理办法！落实医疗器械临床试验机构由“资质认定”改为“备案管理”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=518810e85086)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890684, encodeId=8988189068499, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=征求意见！CFDA将对临床试验审评审批程序与方式作调整, objectType=article, longId=123563, objectId=d7a21235636f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7a21235636f, replyNumber=0, likeNumber=0, createdTime=2018-05-20, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7a21235636f, moduleTitle=征求意见！CFDA将对临床试验审评审批程序与方式作调整, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7a21235636f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890685, encodeId=8427189068506, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA发两通告停止两医械产品进口, objectType=article, longId=123589, objectId=7a0d12358911, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a0d12358911, replyNumber=0, likeNumber=0, createdTime=2018-08-08, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a0d12358911, moduleTitle=CFDA发两通告停止两医械产品进口, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a0d12358911)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890666, encodeId=3ba4189066657, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA深化药品审评审批制度改革打出“组合拳”, objectType=article, longId=118434, objectId=e512118434a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e512118434a3, replyNumber=0, likeNumber=29, createdTime=2017-12-29, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e512118434a3, moduleTitle=CFDA深化药品审评审批制度改革打出“组合拳”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e512118434a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890661, encodeId=4c1118906616b, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=【CFDA直播实录】解读36条建国后最重大的行业政策！药品医疗器械进入“理想的时代”, objectType=article, longId=115483, objectId=7c8c1154838c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c8c1154838c, replyNumber=0, likeNumber=34, createdTime=2018-09-18, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c8c1154838c, moduleTitle=【CFDA直播实录】解读36条建国后最重大的行业政策！药品医疗器械进入“理想的时代”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c8c1154838c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890690, encodeId=a9c4189069083, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA药品“优审”政策更新，国家临床研究中心成重点, objectType=article, longId=125048, objectId=5c3212504848, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c3212504848, replyNumber=0, likeNumber=30, createdTime=2018-11-20, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c3212504848, moduleTitle=CFDA药品“优审”政策更新，国家临床研究中心成重点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c3212504848)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890658, encodeId=0a02189065814, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA关于16批次药品不合格的通告, objectType=article, longId=114771, objectId=17f7114e7123, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17f7114e7123, replyNumber=0, likeNumber=42, createdTime=2017-12-10, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17f7114e7123, moduleTitle=CFDA关于16批次药品不合格的通告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17f7114e7123)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890681, encodeId=13f71890681b4, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=全球和**的特异性结合性神经肌肉阻滞拮抗药物布瑞亭®（舒更葡糖钠注射液）中国上市 CFDA审评概述, objectType=article, longId=122008, objectId=91ea122008b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91ea122008b6, replyNumber=0, likeNumber=28, createdTime=2018-04-24, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91ea122008b6, moduleTitle=全球和**的特异性结合性神经肌肉阻滞拮抗药物布瑞亭®（舒更葡糖钠注射液）中国上市 CFDA审评概述, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91ea122008b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890680, encodeId=3c05189068076, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=全球用于治疗BRAFV600突变阳性的无法手术切除或转移性黑色素瘤的靶向新药佐博伏® 中国上市 CFDA审评概述, objectType=article, longId=122007, objectId=8d8a12200e1b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d8a12200e1b, replyNumber=0, likeNumber=40, createdTime=2018-08-09, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d8a12200e1b, moduleTitle=全球用于治疗BRAFV600突变阳性的无法手术切除或转移性黑色素瘤的靶向新药佐博伏® 中国上市 CFDA审评概述, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d8a12200e1b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890707, encodeId=67e41890e0756, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA解读：网售医疗器械应有实体店, objectType=article, longId=131200, objectId=a224131200ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a224131200ad, replyNumber=0, likeNumber=41, createdTime=2018-10-31, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a224131200ad, moduleTitle=CFDA解读：网售医疗器械应有实体店, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a224131200ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890644, encodeId=584e189064468, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA全面接轨FDA，年底试行药品电子通用技术文档系统（eCTD）, objectType=article, longId=107193, objectId=b13310e193e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b13310e193e9, replyNumber=0, likeNumber=36, createdTime=2017-10-22, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b13310e193e9, moduleTitle=CFDA全面接轨FDA，年底试行药品电子通用技术文档系统（eCTD）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b13310e193e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890711, encodeId=c3c71890e11d7, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA医械会议，透露监管6大方向, objectType=article, longId=134257, objectId=211b13425e22, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=211b13425e22, replyNumber=0, likeNumber=25, createdTime=2018-06-04, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=211b13425e22, moduleTitle=CFDA医械会议，透露监管6大方向, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=211b13425e22)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890695, encodeId=32e8189069594, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA修订治伤风颗粒非处方药说明书高血压等患者慎用, objectType=article, longId=125836, objectId=18c9125836ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18c9125836ef, replyNumber=0, likeNumber=33, createdTime=2018-11-02, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18c9125836ef, moduleTitle=CFDA修订治伤风颗粒非处方药说明书高血压等患者慎用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18c9125836ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890653, encodeId=963018906531d, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA：药店大整治风暴还在继续, objectType=article, longId=113086, objectId=b66d113086f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b66d113086f0, replyNumber=0, likeNumber=38, createdTime=2018-07-22, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b66d113086f0, moduleTitle=CFDA：药店大整治风暴还在继续, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b66d113086f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890708, encodeId=f6091890e08aa, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA：要查350个药颁重磅文件, objectType=article, longId=131524, objectId=0ca913152461, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ca913152461, replyNumber=0, likeNumber=30, createdTime=2018-05-10, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ca913152461, moduleTitle=CFDA：要查350个药颁重磅文件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ca913152461)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890709, encodeId=73911890e090b, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA公开2017年度药品审评报告, objectType=article, longId=133511, objectId=cda41335111d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cda41335111d, replyNumber=0, likeNumber=30, createdTime=2018-07-20, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cda41335111d, moduleTitle=CFDA公开2017年度药品审评报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cda41335111d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890642, encodeId=a7bb1890642e6, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=临床研究的春天到了？—关于CFDA 53号文, objectType=article, longId=106015, objectId=32a510601590, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32a510601590, replyNumber=0, likeNumber=25, createdTime=2018-03-10, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32a510601590, moduleTitle=临床研究的春天到了？—关于CFDA 53号文, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32a510601590)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890637, encodeId=774a189063e51, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=华杰鸿：CFDA成为国际药品注册标准制订者之一, objectType=article, longId=102785, objectId=098b102e854e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=098b102e854e, replyNumber=0, likeNumber=31, createdTime=2018-02-08, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=098b102e854e, moduleTitle=华杰鸿：CFDA成为国际药品注册标准制订者之一, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=098b102e854e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890694, encodeId=e14618906942d, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA发布首部《中国上市药品目录集》, objectType=article, longId=125592, objectId=fa7e12559239, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa7e12559239, replyNumber=0, likeNumber=25, createdTime=2018-11-13, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa7e12559239, moduleTitle=CFDA发布首部《中国上市药品目录集》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa7e12559239)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CFDA

2020-05-29

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

多家中药生产厂商因“短斤缺两”被CFDA官网曝光

2018-08-06

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA正式发布管理办法！落实医疗器械临床试验机构由“资质认定”改为“备案管理”

2018-01-29

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

征求意见！CFDA将对临床试验审评审批程序与方式作调整

2018-05-20

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA发两通告停止两医械产品进口

2018-08-08

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA深化药品审评审批制度改革打出“组合拳”

2017-12-29

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

【CFDA直播实录】解读36条建国后最重大的行业政策！药品医疗器械进入“理想的时代”

2018-09-18

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA药品“优审”政策更新，国家临床研究中心成重点

2018-11-20

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA关于16批次药品不合格的通告

2017-12-10

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

全球和**的特异性结合性神经肌肉阻滞拮抗药物布瑞亭®（舒更葡糖钠注射液）中国上市 CFDA审评概述

2018-04-24

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

全球用于治疗BRAFV600突变阳性的无法手术切除或转移性黑色素瘤的靶向新药佐博伏® 中国上市 CFDA审评概述

2018-08-09

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA解读：网售医疗器械应有实体店

2018-10-31

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA全面接轨FDA，年底试行药品电子通用技术文档系统（eCTD）

2017-10-22

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA医械会议，透露监管6大方向

2018-06-04

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA修订治伤风颗粒非处方药说明书高血压等患者慎用

2018-11-02

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA：药店大整治风暴还在继续

2018-07-22

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA：要查350个药颁重磅文件

2018-05-10

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA公开2017年度药品审评报告

2018-07-20

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

临床研究的春天到了？—关于CFDA 53号文

2018-03-10

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

华杰鸿：CFDA成为国际药品注册标准制订者之一

2018-02-08

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA发布首部《中国上市药品目录集》

2018-11-13

科室
- - 订阅+
  - 更多科室
工具
服务